Latest Developments in Global Digital Pills Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Digital Pills Market

  • Healthcare
  • May 2024
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

  • In January 2025, CapsoVision, Inc. (U.S.) received FDA clearance for CapsoCam Plus for use in pediatric patients aged two and older. This milestone allows children to benefit from the ease and precision of capsule endoscopy, offering a non-invasive, comfortable diagnostic option that minimizes the stress typically associated with traditional endoscopy procedures
  • In April 2024, PENTAX Medical EMEA launched an innovative Digital Capture Module 9380 to transform medical recording competencies in ENT and speech-language pathology settings. This compact and portable device offers advanced and customizable recording features, addressing the evolving needs of healthcare professionals. The 9380 sets a new benchmark in medical imaging technology through its multi-camera source video recording, seamless recording and playback functionalities, and an intuitive software interface
  • In January 2024, AnX Robotics (U.S.) received FDA clearance for expanded indications of its NaviCam Small Bowel Video Capsule Endoscopy (SB) for both adults and children aged 2 years and older. This important milestone, along with the recent FDA clearance of ProScan, the groundbreaking Al-assisted reading tool for Small Bowel Video Capsule Endoscopy (VCE), firmly positions NaviCam SB as the most advanced technology in small bowel video capsule endoscopy
  • In March 2023, etectRx (U.S.) announced that its digital pill, the ID-Cap System, has surpassed 10,000 ingestions, a significant milestone for the company with a reputation for demonstrating strong results and providing data to accurately track patients' adherence to their oral medications
  • In October 2022, BodyCAP (France) and the Laboratoire d'Informatique Sorbonne Université/CNRS (LIP6) collaborated to combine expertise to develop an ingestible video capsule to detect gastrointestinal diseases